hers weight loss glp-1s with compounded semaglutide Hims & Review (2026) – Forbes Health HIMS to Introduce Compounded GLP-1

Initial launch and availability New drug launches typically start with limited availability, especially for injectable medications that require manufacturing scale-up

For others, a once-weekly injection is simpler than a daily ritual

Current as of 5/1/26 Do your plans cover Weight Loss Drugs (GLP-1) if deemed medically necessary

Dose increases typically occur every 4 weeks, following the clinical trial schedule

The medication is injected once weekly and follows a dose escalation schedule that starts low and gradually increases over 16 to 20 weeks

INDIVIDUAL RESULTS VARY Results from tirzepatide treatment vary significantly between individuals